annual CFF:
$356.04M+$2.52B(+116.47%)Summary
- As of today (September 9, 2025), RPRX annual cash flow from financing activities is $356.04 million, with the most recent change of +$2.52 billion (+116.47%) on December 31, 2024.
- During the last 3 years, RPRX annual CFF has risen by +$15.14 million (+4.44%).
- RPRX annual CFF is now -74.92% below its all-time high of $1.42 billion, reached on December 31, 2020.
Performance
RPRX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$507.81M+$433.49M(+46.05%)Summary
- As of today (September 9, 2025), RPRX quarterly cash flow from financing activities is -$507.81 million, with the most recent change of +$433.49 million (+46.05%) on June 30, 2025.
- Over the past year, RPRX quarterly CFF has dropped by -$1.66 billion (-143.91%).
- RPRX quarterly CFF is now -132.15% below its all-time high of $1.58 billion, reached on June 30, 2020.
Performance
RPRX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$2.03B-$1.66B(-452.10%)Summary
- As of today (September 9, 2025), RPRX TTM cash flow from financing activities is -$2.03 billion, with the most recent change of -$1.66 billion (-452.10%) on June 30, 2025.
- Over the past year, RPRX TTM CFF has dropped by -$1.39 billion (-214.27%).
- RPRX TTM CFF is now -230.67% below its all-time high of $1.56 billion, reached on June 30, 2020.
Performance
RPRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RPRX Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +116.5% | -143.9% | -214.3% |
3 y3 years | +4.4% | -122.5% | -625.3% |
5 y5 years | +129.9% | -132.2% | -230.7% |
RPRX Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +116.5% | -143.9% | +62.6% | -624.9% | +6.9% |
5 y | 5-year | -74.9% | +116.5% | -132.2% | +62.6% | -230.7% | +6.9% |
alltime | all time | -74.9% | +116.5% | -132.2% | +62.6% | -230.7% | +6.9% |
RPRX Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$507.81M(-46.1%) | -$2.03B(+452.1%) |
Mar 2025 | - | -$941.30M(+264.9%) | -$368.16M(-201.9%) |
Dec 2024 | $356.04M(-116.5%) | -$257.96M(-20.7%) | $361.14M(-6.7%) |
Sep 2024 | - | -$325.50M(-128.1%) | $387.21M(-159.9%) |
Jun 2024 | - | $1.16B(-645.6%) | -$646.77M(-69.9%) |
Mar 2024 | - | -$212.00M(-8.6%) | -$2.15B(+0.1%) |
Dec 2023 | -$2.16B(+127.0%) | -$231.89M(-82.9%) | -$2.15B(-1.5%) |
Sep 2023 | - | -$1.36B(+291.8%) | -$2.18B(+107.3%) |
Jun 2023 | - | -$347.00M(+64.9%) | -$1.05B(+12.7%) |
Mar 2023 | - | -$210.37M(-20.8%) | -$934.26M(-1.1%) |
Dec 2022 | -$952.05M(-379.3%) | -$265.55M(+15.4%) | -$944.86M(+7.7%) |
Sep 2022 | - | -$230.09M(+0.8%) | -$877.38M(-326.7%) |
Jun 2022 | - | -$228.25M(+3.3%) | $386.98M(-1.0%) |
Mar 2022 | - | -$220.97M(+11.6%) | $390.82M(+1.5%) |
Dec 2021 | $340.90M | -$198.07M(-119.2%) | $385.11M(+25.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $1.03B(-560.9%) | $305.79M(-128.2%) |
Jun 2021 | - | -$224.41M(-1.0%) | -$1.09B(-251.2%) |
Mar 2021 | - | -$226.67M(-18.3%) | $717.98M(-51.7%) |
Dec 2020 | $1.42B(-219.1%) | -$277.39M(-22.4%) | $1.49B(+0.6%) |
Sep 2020 | - | -$357.39M(-122.6%) | $1.48B(-4.9%) |
Jun 2020 | - | $1.58B(+191.1%) | $1.56B(-565.5%) |
Mar 2020 | - | $542.52M(-289.8%) | -$334.15M(-72.0%) |
Dec 2019 | -$1.19B(-13.6%) | -$285.80M(+1.8%) | -$1.19B(+31.6%) |
Sep 2019 | - | -$280.69M(-9.5%) | -$905.82M(+44.9%) |
Jun 2019 | - | -$310.18M(-1.5%) | -$625.13M(+98.5%) |
Mar 2019 | - | -$314.96M | -$314.96M |
Dec 2018 | -$1.38B(+1018.9%) | - | - |
Dec 2017 | -$123.25M(-86.7%) | - | - |
Dec 2016 | -$923.32M(>+9900.0%) | - | - |
Dec 2015 | -$6.75M | - | - |
FAQ
- What is Royalty Pharma plc annual cash flow from financing activities?
- What is the all time high annual CFF for Royalty Pharma plc?
- What is Royalty Pharma plc annual CFF year-on-year change?
- What is Royalty Pharma plc quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly CFF year-on-year change?
- What is Royalty Pharma plc TTM cash flow from financing activities?
- What is the all time high TTM CFF for Royalty Pharma plc?
- What is Royalty Pharma plc TTM CFF year-on-year change?
What is Royalty Pharma plc annual cash flow from financing activities?
The current annual CFF of RPRX is $356.04M
What is the all time high annual CFF for Royalty Pharma plc?
Royalty Pharma plc all-time high annual cash flow from financing activities is $1.42B
What is Royalty Pharma plc annual CFF year-on-year change?
Over the past year, RPRX annual cash flow from financing activities has changed by +$2.52B (+116.47%)
What is Royalty Pharma plc quarterly cash flow from financing activities?
The current quarterly CFF of RPRX is -$507.81M
What is the all time high quarterly CFF for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly cash flow from financing activities is $1.58B
What is Royalty Pharma plc quarterly CFF year-on-year change?
Over the past year, RPRX quarterly cash flow from financing activities has changed by -$1.66B (-143.91%)
What is Royalty Pharma plc TTM cash flow from financing activities?
The current TTM CFF of RPRX is -$2.03B
What is the all time high TTM CFF for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM cash flow from financing activities is $1.56B
What is Royalty Pharma plc TTM CFF year-on-year change?
Over the past year, RPRX TTM cash flow from financing activities has changed by -$1.39B (-214.27%)